INTRODUCTION
Patients with systemic lupus erythematosus (SLE)' frequently have cold-reactive serum lymphocytotoxic antibodies (1-4), which are detected by various modifications of the original microcytotoxicity test (5) ; these antibodies appear to be mainly immunoglobulin (Ig)M but probably represent only part of a broad spectrum of anti-lymphocyte responses present in patients with SLE (6) (7) (8) (9) . Anti-lymphocyte antibodies associated with active SLE show varying degrees of reactivity for lymphocyte subpopulations. Thus, whole serum or IgG fractions of some SLE sera are capable of blocking mixed leukocyte culture reactivity by interaction with responder lymphocyte populations (10, 11) . In addition, reactions with both T and B lymphocytes have been detected using other techniques (8, 12, 13) . One possible explanation for the original genesis of antilymphocyte antibody in SLE serum might be that intrinsic alterations in lymphocyte membranes could be induced by the disease itself (14) . If, for instance, a virus was resident within SLE lymphocytes, it might induce an immune response by coding for alterations in various cell surface membrane structures. Such a circumstance might favor production of anti-lymphocyte antibody with specificity for altered autologous membrane components but with cross-reactivity for normal lymphocyte cell surface structures. Alternative possibilities are that SLE anti-lymphocyte antibodies recognize derepressed gene products or idiotypic antigens on expanded clones of antigen-reactive lymphou Abbreviations used in this paper: ALL, acute lymphoblastic leukemia; E, erythrocyte; FACS, Fluorescence-Activated Cell Sorter; Fc crystalline fragment; PMN, polymorphonuclear leukocyte; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus. cvtes in SLE. Examination of these possibilities is made difficult by the broad heterogeneity of antibodies in SLE; we halve therefore adopted a different approach and have sought direct evidence for the existence of new or altered antigens on SLE lymphocytes by heteroimmunization. A general approach was used for immunizing against weak cell surf'ace antigens that has previously been successful in defining antigens associated with acute lymphoblastic leukemila (15) (16) (17) . The results presented here provide preliminary evidence for the presence of unusual SLE lymphocyte membrane antigens which may be related to the disease process itself.
METHODS
Peripheral blood samiiples were collected in preservative-free heparin from 48 patients with active SLE as judged by presence of high DNA-binding, low total serum hemolytic complement, clinical evidence of renal or central nervous system involvement, active skin lesions, arthritis or tendonitis, or generalized polyserositis. All patients met preliminary Arthritis Rheumatism Association criteria (18) for a definite diagnosis of SLE. Although no evidence was available at the beginning of the study to the conitrary', a conscious attempt was made to avoid collection of blood samples from more than a few patients receiving high (lose (>20 mg/d) prednisone or other corticosteroids or from patients wvho had been maintainied on other imnmunosuppressive regimes such as azathioprine, cyclophosphamide, or chlorambucil. The degree of clinical activity was arbitrarily graded as mild, moderate, or severe on the basis of concurrent clinical and laboratory findings. Thus, patients classified as showing severe activity manifested fever, multisvstemii involvement, significant leukopenia (leukocyte count < 3,500) and synovitis, active central nervous system signs, or active nephropathy. Patients with moderate involvement showed no fever or ongoing evidence of multisystem involvement but showed clinical and laboratory signs of activity in at least one major system such as nephropathy, thrombocytopenia, central nervous system involvement, or synovitis. SLE patients with mild activity showed only episodic, symptomatic minor flares of disease usually without concurrent marked change in serumii comiplement profile, DNA binding, or ancillary laboratory parameters. Over half (27/48) of the patients studied were regarded as showing severe involvement and 19 were studied before any therapy was administered.
Control groups studied included 25 normal subjects of both sexes (ages 20-50 yr) as well as a group of patients with other connective tissue diseases including 24 with rheumatoid arthritis, 4 with mixed connective tissue disease, 5 with scleroderma, 1 with polymyositis, and 1 with periarteritis nodosa. In addition, 21 miscellaneous patients (ages 22-80 yr) of both sexes representing a number of common medical problems such as myocardial infarction, obstructive lung disease, diabetes, viral pneumonia, pulmonary infarction, alcoholic liver disease, tuberculosis, or gonococcal sepsis were also studied.
Lymphocytes were isolated from blood samples using Ficoll (Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscata- way, N. J.)-triosil density sedimentation (19) , and depleted of monocytes and adherent cells by incubation at 37°C for 45 min on glass petri dishes as previously described (20) . This procedure also allowed for shedding of any cytophilic Ig passively absorbed to the test cells. In some experiments, lvmphocytes were separated into erythrocyte (E)-rosetting and nonrosetting stubpopulaltions using neuraiminidase E rosettes and centrifugation through a Ficoll-triosil gradient as previously described (21) . Nonrosetting cells at the Ficoll-triosil interface were almost entirely B and "null" cells as indicated by fluoreseence staining for surface immunoglobtulin uising pepsin-digested rabbit anti-human immunoglobtulin (21) as well as by' staining with chicken anti-human Ila antibody followed by goatt anti-chicken y-globuliin fluioresceinalted aintibody (22, 2:3 (15, 16) . 1 wk after the third injection of pooled SLE lymphocytes, rabbits were bled out and antisenim absorbed.
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Control immunizations were conducted in identical protocols using lymphocytes isolated from fresh normal human tonsils after mincing, filtration through wire mesh, and extensive washing with Hanks' balanced salt solution. 300-400 x 106 living tonsillar lymphocytes were used for each of a series of three weekly intravenous injections. Again normal tonsillar lymphocytes were precoated with rabbit antiserum to normal tonsils and normal human thymus before intravenous immunizations. A second control group of immunizations inclided similar numbers of peripheral blood lymphocytes obtained from at least 10 different patients with active rheumatoid arthritis (RA). Cells from RA patients were collected, stored after freezing in a programmed cell freezer, and later pooled to provide batches of cells used for intravenous immunizations of three rabbits. All pools of RA lymphocytes were precoated with rabbit antibody to normal human tonsillar cells and human thymocytes before intravenous immunizations.
Absorption procedures. Antisera were first inactivated at 56°C for 30 min. They were then absorbed 4 times with onethird volume of freshly washed human AB erythrocytes, 7-10 times with one-third volume of freshly prepared washed human tonsillar lymphocytes, and 2-3 times with one-third volume of human thymus cells obtained from fresh samples of thymus removed during cardiac surgery, and twice with normal peripheral blood lymphocytes. Antisera were also absorbed twice with one-third volume of washed leukocytes from patients with chronic granulocytic leukemia, once with lymphocytes from patients with chronic lymphatic leukemia, and once with cells from patients vith myelogenous leukemia in blast crisis. All absorptions were carried out at 4°C for 2-4 h with frequent agitation of cell pellets to mix absorbing cells with antiserum. Toward the end of these extensive absorption procedures, absorbing cells were monitored by indirect immunofluorescence using fluorescein-labeled goat anti-rabbit y-globulin to detect surface rabbit IgG still being absorbed out by the respective absorbent cell preparations.
After absorption appeared complete and no more rabbit Ig was detected on absorbing cells by indirect immunofluorescence, whole antisera were then digested with pepsin at pH 4.0 to produce F(ab)2' fragments devoid of Fc. Completeness of peptic digestion was monitored using acrylamide gel electrophoresis, Ouchterlony analysis with specific goat anti-rabbit Fc antibody, and absorption with whole Cowan I staphylococcal organisms containing protein A, or with protein A linked to Sepharose. Whole absorbed antiserum was pepsin digested at pH 4.0, 37°C, using 2 mg pepsin/ml of whole serum. After 14 h of pepsin digestion, the precipitate was pelleted in the ultracentrifuge by centrifugation at 20,000 g for 30 min, and supernates were redigested with pepsin a second time again using 2 mg/ml serum over a 10-h period. At the end of the second digestion, insoluble precipitate was again cleared by ultracentrifugation. The supernate containing F(ab)2' fragments was then dialyzed overnight for 12 h against 0.005 M, pH 7.5, phosphate buffer. After this dialysis step the material was absorbed with protein A linked to Sepharose and cleared in the preparative ultracentrifuge at 100,000 g using a 10 x 10-in. head and the cleared supernate containing F(ab)2' fragments of antibody adjusted to pH 7.4 and 0.1 molarity for use in cell membrane immunofluorescence studies.
Pepsin-digested whole absorbed antisera were incubated with normal or patient lymphocytes or PMN for 30 min at 22°C, washed with RPMI medium, and fluorescein-labeled goat F(ab)2' fragments of anti-rabbit F(ab)2' applied, washed once, and cell preparations mounted under sealed cover slips and examined under incident light using phase and UV immunofluorescence microscopy. The goat F(ab)2' anti-rabbit F(ab)2' antibody had been specifically isolated by affinity chromatography from a solid-phase rabbit F(ab)2' column and only specific eluted antibody labeled with fluorescein. This reagent showed no reactivity with isolated rabbit Fc fragment by Ouchterlony analysis. In all immunofluorescence procedures controls included F(ab)2' fragments derived from normal rabbit serum as well as application of the fluorescein isothiocyanate-labeled goat F(ab)2' anti-rabbit F(ab)2' alone.
In some cases monocyte and adherent cell-depleted lymphocyte cell populations from both SLE patients and normal controls were studied after separation oflarge and small mononuclear cells with the Becton, Dickinson Fluorescence-Activated Cell Sorter (FACS-1, Becton, Dickinson FACS Systems, Mountain View, Calif.). The principles and details of the FACS operation have previously been described (24) (25) (26) . In addition, sorting for intensity of fluorescence and cell profile was also performed using whole Ficoll-triosil lymphocyte preparations from patients with active SLE in comparison to normal controls.
RESULTS
Studies using absorbed pepsin-digested antisera. After the extensive absorptions noted above, pepsindigested antisera made against SLE lymphocytes from two of the three rabbit antisera appeared to show preferential reactivity for membrane determinants present on mononuclear cells from SLE patients. Some residual staining was noted in a small population of normal control cells studied in parallel; Possible nonspecific background staining was calculated from control experiments where pepsin-digested normal rabbit serum was applied before addition of the fluoresceinlabeled specific goat F(ab)2' anti-rabbit F(ab)2'. In these control experiments, 1.8-5% of normal, rheumatoid, or test SLE cells showed a low level of apparent background binding. A summary of data obtained in these experiments is given in Table I .
In many of these assays whole monocyte-depleted lymphocytes were tested in parallel with nonrosetting and neuraminidase E-rosetting T lymphocytes as well as PMN isolated by initial dextran sedimentation before Hypaque-triosil mononuclear cell preparation. All PMN preparations were studied within <3 h of initial blood collection. Several interesting points can be noted in the data shown in Table I . In patients 3 and 5, after a 45-min incubation at 37°C, relatively low proportions of lymphocytes were stained (5 and 17%);however, again much higher proportions of lymphocyte subpopulations (80, 56, and 72%) showed staining after overnight 37°C incubation using the same pepsindigested antisera. Relatively low proportions of cells were noted staining in normal subjects, miscellaneous disease controls, and other connective tissue disease patients studied. Also it appeared that anti-SLE antisera were reacting wth membrane determinants that were present on both nonrosetting and T-rosetting cells. However, in most SLE patients, higher proportions of neuraminidase-rosetting cells showed positive staining. This was particularly striking in patients 4, 6, 12, and 13, all of whom were untreated with exSyste7nic Lupus Erythematosus Lymphocyte Antigens Control observations using absorbed pepsin-digested antisera to normal human tonsillar lymphocytes and other similarly processed antisera made against pooled RA lymphocytes showed no similar specificity. Pepsindigested absorbed antisera to normal human tonsils produced essentially negative results with 15 normal controls, 12 patients with RA, and 10 patients with active SLE. In similar fashion, no rheumatoid specificity was apparent when three different rabbit antisera against RA lymphocytes absorbed and pepsin digested in similar protocols were studied using SLE, RA, and normal control lymphocytes. A summary of these control experiments is shown in Table II . Data for one anti-RA antiserum shown in (B) was similar to that recorded with two other separate anti-RA lymphocyte antisera.
During the course of these studies it appeared that the reactivity of the absorbed pepsin-digested anti-SLE lymphocyte antisera was higher in percentage of cells staining using freshly collected SLE lymphocytes than with cells previously obtained from the samiie patients and stored frozen for several weeks or months in liquid nitrogen. It was also found that when freshly collected lymphocytes were recovered from Ficoll-triosil and not allowed to elute possible cytophilic antibody at 37°C, a much lower proportion of positively staining cells was identified. Subsequently after overnight incubation at 37°C in 5% CO2 air, the proportion of positively staining cells increased markedly.
A number of observations appeared to be consistent with a relative loss of positively staining lymphocytes in SLE patients receiving moderate or high doses of corticosteroids. Therefore it was very unusual to see > 10-15% positively staining lymphocytes in SLE subjects taking over 20 mg prednisone/d. Serial studies in several patients showed decreases from initial percentage positivity of 55-70% in whole monocyte-depleted lymphocytes during initial active untreated SLE to 10-20% positive cells within several days after institutioin 382 Williams, Hughes, Snaith, Parry, Diao, and Greaves Absorbed pepsin-digested anti-SLE antisera were next studied using monocyte-depleted lymphocyte preparations from patients with active SLE in comparison to PMN isolated from the same patients. 0.2 ml antiserum was absorbed with 3-5 x 106 lymphocytes or 5 X 106 PMN collected initially on ice at 4°C. Membrane staining of lymphocytes was markedly reduced both in intensity and proportion of cells staining using two absorptions at 4°C for 3 h with SLE lymphocytes; in addition marked reduction of staining PMN occurred after lymphocyte absorption ofantisera. Conversely, parallel absorption of pepsin-digested antiserum with PMN also reduced staining for both lymphocytes and PMN. Results of two separate experiments are summarized in Table IV . It appeared that antigens recognized by the anti-SLE antisera were more easily removed by absorption with lymphocytes than with PMN. Studies with cell lines. The experiments described above indicated that the extensively absorbed anti-SLE reagents reacted with both E-rosetting and nonrosetting cells from peripheral blood of SLE subjects. A number ofhuman cell lines were also tested for reactivity with the same anit-SLE reagents. Results of these experiments are shown in Table V . Of interest was the relatively high proportion of cells (22%) staining in one T-(ALL) cell line (CCRF/CEM). However, controls with pepsin-digested normal rabbit IgG were high (9%) with this line. No significant increment in staining was noted with either Ia+ B-cell lines or the lines REH and NALM-6-1 originally obtained from patients with non-T and non-B ALL (27) .
Studies on SLE renal biopsy tissue. One of the patients showing high proportions (58%) of cells staining with absorbed pepsin-digested anti-SLE lymphocyte serum underwent renal biopsy during the time of the study. An opportunity was therefore afforded for direct examination of fresh renal tissue in this patient. These studies were performed in conjuction with routine immunofluorescence using anti-C3, anti-IgG, IgA and IgM which showed only traces of glomerular immune deposits in parallel with apparently normal conventional microscopic appearance in glomeruli included within the biopsy core. In several areas, however, hematoxylin and eosin stains showed significantly increased interstitial renal accumulations of lymphocytes. Application ofpepsin-digested absorbed anti-SLE lymphocyte antiserum followed by fluorescein-conjugated F(ab)2' goat anti-rabbit F(ab)2' showed staining of 80% of these interstitial renal lymphocyte accumulations. No significant staining of glomeruli, renal tubular cells, or discrete areas in conjunction with the traces of glomerular immune deposits was noted. Double staining of renal interstitial lymphoid infiltrates using rhodamine-conjugated sheep anti-chicken y-globulin and chicken anti-human Ia in parallel with rabbit anti-SLE lympocyte F(ab)2' and fluorescein-labeled F(ab)2' goat anti-rabbit F(ab)2' indicated that 25% of the positively staining lymphoid cells reacting with the absorbed anti-SLE lymphocyte reagent were also Ia+.
Attempts were also made to stain renal biopsy frozen sections on four SLE patients with lupus nephropathy who had undergone kidney biopsies in the recent past where frozen material was still available for examination. Sections were overlaid with pepsin-digested whole absorbed anti-SLE antiserum, washed, and stained with fluorescein isothiocyanate F(ab)2' antirabbit F(ab)2'. Although all of these latter sections showed immune deposits characterized by glomerular Ig and C granular immunofluorescence, no staining of immune deposits or other areas was noted with the anti-SLE reagents.
FACS analysis. The FACS was used in a number of experiments to obtain an analysis of the general size Systemic Lupus Ertjthematosus Lymphocyte Antigens It seems unlikely that staining activity of the rabbit anti-SLE lymphocyte antibodies produced by these procedures could be accounted for by anti-HLA activity, sinice no resultant specificity for the immunizing cells could be detected and low or negative values for staining were noted in a large number of controls. Expressioni of lymphocyte memiibraine antigens was particularly high (40-70%) in some patients with untreated active SLE. Subsequent decrease in proportions ofpositive cells after corticosteroid or immunosuppressive therapy also appears to argue against any direct HLArelated antigen.
One of the most important problems related to the studies presented here lies in the technical difficulties associated with the presence of Fc receptors on a number of mnononuclear cell populations (28) (29) (30) (31) (32) (34, 35) .
Whether or not some of the SLE cells staining with pepsin-digested absorbed antisera may in fact repre-sent an increase in lymphocyte binding through receptors for F(ab)2' at present is not clear. After peptic digestion of absorbed anti-SLE antisera, there still appeared to be preferential staining of anti-SLE reagents for SLE lymphoid cells. Some ofthis staining could conceivably be related to binding of F(ab)2' fragments to the recently described receptor for the latter on normal lymphoid cells (36) . However, control observations using identically absorbed and pepsin-digested antisera to both normal human tonsillar lymphocytes and pooled cells from RA patients did not show similar specificity or increased proportions of positive staining with SLE lymphocytes.
Double marker studies indicated that SLE-reactive membrane antigens were present on both B and T cells, but that in many instances T-cell fractions showed a higher degree of reactivity than did non-Trosetting cells or B cells as monitored by concurrent anti-Ia and rhodamine staining. Presently there is no evidence that the lymphocyte membrane antigen(s) detected with the extensively absorbed anti-SLE antisera described here have any relationship to virus or cell surface determinants related to any viral genome (37) (38) (39) (40) . Considerably more work will be necessary before such a possibility can be resolved.
Recent observations by Curd et al. (41) may have some relevance to the findings reported in this study. Presence of a neoantigen of the membrane attack complex of human complement was identified on peripheral blood lymphocytes as well as PMN in patients with SLE. Because the antigen identified by Curd et al. (41) appeared to predominate on granulocytes, such a circumstance could explain our findings of staining a high proportion of PMN in patients with active SLE. Further studies including attempts to block the reactions produced by our antisera with unlabeled antisera reacting with complement neoantigens will be necessary before this question can be resolved. Thus far absorption studies have not provided any direct evidence for different antigens detected by the anti-SLE antisera on lymphocytes and PMN. Absorption with SLE lymphocytes markedly reduced or virtually eliminated lymphocyte membrane staining whereas, PMN staining was also reduced but not as dramatically. Conversely using SLE PMN for absorption, considerable reduction in staining of both lymphocytes and PMN was recorded. If material within the PMN was derived from lymphocyte fragments in vivo, it may well be that PMN used as absorbents were not as efficient or sterically hindered by presence of antigens within confines of cell membranes.
From a different standpoint, it is also conceivable that the lymphocyte cell surface antigens recognized by the highly absorbed anti-SLE lymphocyte antisera were reacting with essentially normal cell surface antigens either increased in density on SLE lymphocyte membranes or altered antigenically as a result of the disease. Further investigation of the specificitv of anti-SLE lymphocyte sera with respect to these various possibilities now requires immunochemnical isolationi of the cell surface molecules involved.
